financetom
Business
financetom
/
Business
/
Emergent Biosolutions Insider Bought Shares Worth $349,800, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Emergent Biosolutions Insider Bought Shares Worth $349,800, According to a Recent SEC Filing
May 26, 2025 9:00 AM

04:12 PM EDT, 05/15/2025 (MT Newswires) -- Joseph C Papa, Director, President and CEO, on May 13, 2025, executed a purchase for 60,000 shares in Emergent Biosolutions ( EBS ) for $349,800. Following the Form 4 filing with the SEC, Papa has control over a total of 342,500 common shares of the company, with 342,500 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1367644/000136764425000127/xslF345X05/wk-form4_1747339349.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lilly CEO says tax and regulation reform, drug affordability are focuses under Trump
Lilly CEO says tax and regulation reform, drug affordability are focuses under Trump
Dec 10, 2024
(Reuters) - Eli Lilly CEO David Ricks on Tuesday said at the Economic Club of Washington that tax and regulation reform and drug affordability were some policy focuses for the company in a second Trump administration. President-elect Donald Trump met with Ricks and the chief executive of industry lobbying group PhRMA in Florida last week. It was also reported that...
Adidas headquarters raided in years-long tax investigation, Bloomberg News reports
Adidas headquarters raided in years-long tax investigation, Bloomberg News reports
Dec 10, 2024
Dec 10 (Reuters) - Authorities raided Adidas AG headquarters in Germany as part of a years-long tax investigation, Bloomberg News reported on Tuesday. Adidas told Bloomberg that it has been in contact with customs authorities for several years about the matter and is providing them with documents and information. ...
Lilly CEO says tax and regulation reform, drug affordability are focuses under Trump
Lilly CEO says tax and regulation reform, drug affordability are focuses under Trump
Dec 10, 2024
Dec 10 (Reuters) - Eli Lilly ( LLY ) CEO David Ricks on Tuesday said at the Economic Club of Washington that tax and regulation reform and drug affordability were some policy focuses for the company in a second Trump administration. President-elect Donald Trump met with Ricks and the chief executive of industry lobbying group PhRMA in Florida last week....
Air France-KLM upbeat on Brazil in 2025 after year of expansion
Air France-KLM upbeat on Brazil in 2025 after year of expansion
Dec 10, 2024
SAO PAULO (Reuters) - Air France-KLM is optimistic about the Brazilian market for 2025 after posting positive results in the country this year, executives for the European carrier in Latin America's largest economy told reporters on Tuesday. WHY IT'S IMPORTANT South America is the second biggest long-haul area for Air France-KLM after North America, and Brazil was a key investment...
Copyright 2023-2026 - www.financetom.com All Rights Reserved